Hims & Hers buys Australian digital health firm for $1.15bn Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health.

Facing the legal consequences of its aborted entry into the #oralGLP1 category in the #US, #telehealth company #HimsandHers has turned its attention to international matters with an agreement to buy #Australian rival #EucalyptusHealth.

"Want to lose weight without needles? Ai.DrMedHealth.com’s Oral GLP-1 ($399/month) offers powerful GLP-1 benefits in a daily tablet. Achieve weight loss with expert medical guidance and no hidden fees. Start your transformation with our free health assessment today! #OralGLP1 #WeightLossMadeEasy"

Eli Lilly Logo

Eli Lilly’s oral GLP-1 orforglipron posts successful Phase 3 results with 10.5 % weight loss and A1C reduction in obese and T2D patients. Analysts note its small-molecule cost edge over Novo’s semaglutide.

jcst2d.com/index.php?vi...

#orforglipron #Lilly #oralGLP1 #Phase3 #T2D